Concert Pharmaceuticals, Inc. (CNCE) Social Stream

Concert Pharmaceuticals, Inc. (CNCE): $4.31

0.05 (+1.17%)

POWR Rating

Component Grades













Add CNCE to Watchlist
Sign Up

Industry: Biotech


of 396

in industry

Concert Pharmaceuticals Inc (CNCE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Concert Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 5 $25 $9 $17 $3.58 374.86%
2022-03-04 4 $22 $9 $14.375 $3.58 301.54%

The Trend in the Analyst Price Target

Over the past 14 months, CNCE's average price target has gone down $9.75.

CNCE reports an average of 306.68% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 1 22 11 15.33 4.33 254.04%
2021-08-05 1 22 11 15.33 3.56 330.62%
2021-11-10 1 22 9 14.25 4.22 237.68%
2021-11-10 4 25 9 16.40 4.22 288.63%
2022-03-04 3 22 9 14.25 2.88 394.79%

CNCE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations

Over the past 151 days, CNCE's average broker recommendation rating improved by 0.83.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Concert Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 745.2% of them.
  • CNCE has a lower variance in analysts' estimates than -621.51% of all US stocks.
  • In terms of how Concert Pharmaceuticals Inc fares relative to all US stocks, note that its average analyst price target is greater than 126.82% of that group.
  • CNCE has a higher number of analysts covering the stock than 144.38% of all US stocks.

Stocks similar to Concert Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CMPS, CLVR, and CLSD.

What is the outlook for CNCE? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.573 seconds.